Complete the form and download the white paper
Next-generation sequencing (NGS) is rapidly advancing immunology and immuno-oncology research, with the latest solution enabling researchers to study T-cell receptor (TCR) convergence accurately. Read the white paper to learn about TCR convergence and its emergence as a potential biomarker. Understand why choosing the right NGS solution is important for detecting convergence and how researchers are applying it in such fields of research as:
- Checkpoint inhibitors (CPIs)
- Vaccine research
- Viral infection research
